Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Gu

Showing results (1091-1100 of 1,173) with videos related to

Pageof 118
Sort By:
Journal of Nanobiotechnology|January 19, 2025
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.
Zhonghua Nei Ke Za Zhi|April 21, 2006
[Expression and significance of severe acute respiratory syndrome associated coronavirus (SARS-CoV)-X4 protein in lungs of SARS patients]Ya-xia Tan, Tao Chen, Shu-qing Zhong, et al.
Nature Communications|May 20, 2022
Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cellsJiawei Zhang, Yichao Gan, Hongzhi Li, et al.
Science Bulletin|December 30, 2023
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibodyZhiping Wang, Daning Wang, Jie Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Viral neutralization by antibody-imposed physical disruptionQingbing Zheng, Jie Jiang, Maozhou He, et al.
Journal of Nanobiotechnology|July 2, 2025
Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunityYarong Zeng, Yifan Yin, Jialin Xu, et al.
Cancer Cell|July 12, 2017
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell LymphomaYing Gu, Jiawei Zhang, Xiaoxiao Ma, et al.
Journal of Virology|January 21, 2021
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of bindingMaozhou He, Xin Chi, Zhenghui Zha, et al.
NPJ Vaccines|November 1, 2022
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.
Trials|December 19, 2021
Feasibility and effectiveness of prone position ventilation technique for postoperative acute lung injury in infants with congenital heart disease: study protocol for a prospective randomized studyYu-Lu Xu, Ya-Ping Mi, Meng-Xin Zhu, et al.
Pageof 118

Showing results (1091-1100 of 1,173) with videos related to

Sort By:
Pageof 118
Journal of Nanobiotechnology|January 19, 2025
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sitesCiying Qian, Jie Chen, Yurou Yang, et al.
Zhonghua Nei Ke Za Zhi|April 21, 2006
[Expression and significance of severe acute respiratory syndrome associated coronavirus (SARS-CoV)-X4 protein in lungs of SARS patients]Ya-xia Tan, Tao Chen, Shu-qing Zhong, et al.
Nature Communications|May 20, 2022
Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cellsJiawei Zhang, Yichao Gan, Hongzhi Li, et al.
Science Bulletin|December 30, 2023
Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibodyZhiping Wang, Daning Wang, Jie Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2019
Viral neutralization by antibody-imposed physical disruptionQingbing Zheng, Jie Jiang, Maozhou He, et al.
Journal of Nanobiotechnology|July 2, 2025
Novel adjuvant delivery system constructed by alum-emulsion hybrid nanoparticles with TLR9 agonists boosts vaccine immunityYarong Zeng, Yifan Yin, Jialin Xu, et al.
Cancer Cell|July 12, 2017
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell LymphomaYing Gu, Jiawei Zhang, Xiaoxiao Ma, et al.
Journal of Virology|January 21, 2021
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of bindingMaozhou He, Xin Chi, Zhenghui Zha, et al.
NPJ Vaccines|November 1, 2022
Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70Ciying Qian, Yurou Yang, Qin Xu, et al.
Trials|December 19, 2021
Feasibility and effectiveness of prone position ventilation technique for postoperative acute lung injury in infants with congenital heart disease: study protocol for a prospective randomized studyYu-Lu Xu, Ya-Ping Mi, Meng-Xin Zhu, et al.
Pageof 118